companydata.dkcompanydata.dk

Nectar Willeshave P/S: Financial statements 2023

CVR: 41735821

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Nectar Willeshave P/S (CVR 41735821) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,668,626 and a net result of DKK 105,298 compared with DKK 8,877,585 the year before. That is an increase of 1,273.1% compared with the year before. Equity in the 2023 report amounted to DKK 27,195,619. The solvency ratio was 30.1%.

Gross Profit
DKK 3,668,626
Profit/Loss
DKK 105,298
Equity
DKK 27,195,619
Total Assets
DKK 90,306,516
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-3.7 mio.105 t.27.2 mio.0
2022-267 t.8.9 mio.27.1 mio.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

PharmaService I/S registered as owner of Nectar Willeshave P/SOct 31, 2023

As of October 31, 2023, PharmaService I/S is registered as an owner of Nectar Willeshave P/S with an ownership share of 90%.

Nectar Invest A/S registered as owner of Nectar Willeshave P/SOct 31, 2023

As of October 31, 2023, Nectar Invest A/S is registered as an owner of Nectar Willeshave P/S with an ownership share of 10%.

Nectar Willeshave P/S: The 2022 annual report is outJun 22, 2023

Nectar Willeshave P/S has published its annual report for 2022. Gross profit came to DKK 267,171, and the net result was DKK 8,877,585.

About Nectar Willeshave P/S

Nectar Willeshave P/S is a Danish company of the type Kommanditaktieselskab/Partnerselskab based in København K, founded in 2020. The company is registered under the industry Gennemførelse af byggeprojekter. The company was previously named PROJEKTSELSKABET KØGE B11/B12 P/S. The management consists of Bjørk Krogshave. The board consists of Peer Thomas Borg (chair), Bjørk Krogshave and Peter Graversen. The company is owned by PharmaService I/S and Nectar Invest A/S. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 3,642,887 and a net result of DKK 3,130,361 compared with DKK 1,065,152 the year before. Equity in the 2025 report amounted to DKK 31,391,132.

Source: annual report 2025, Danish Business Authority

Other financial years